Literature DB >> 25347147

Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields.

Karl T Butterworth1, Kelly M Redmond, Stephen J McMahon, Aidan J Cole, Suneil Jain, Helen O McCarthy, Joe M O'Sullivan, Alan R Hounsell, Kevin M Prise.   

Abstract

PURPOSE: To determine differences in overall tumor responses measured by volumetric assessment and bioluminescence imaging (BLI) following exposure to uniform and non-uniform radiation fields in an ectopic prostate tumor model.
MATERIALS AND METHODS: Bioluminescent human prostate tumor xenografts were established by subcutaneous implantation into male mice. Tumors were irradiated with uniform or non-uniform field configurations using conventional in vivo irradiation procedures performed using a 225 kVp generator with custom lead shielding. Tumor responses were measured using Vernier calipers and by BLI using an in vivo imaging system. Survival was defined as the time to quadroupling of pre-treatment tumor volume.
RESULTS: The correlation between BLI and tumor volume measurements was found to be different for un-irradiated (R = 0.61), uniformly irradiated (R = 0.34) and partially irradiated (R = 0.30) tumors. Uniformly irradiated tumors resulted in an average tumor growth delay of 60 days with median survival of 75 days, compared to partially irradiated tumors which showed an average growth delay of 24 days and median survival of 38 days.
CONCLUSIONS: Correlation between BLI and tumor volume measurements is lower for partially irradiated tumors than those exposed to uniform dose distributions. The response of partially irradiated tumors suggests non-uniformity in response beyond physical dose distribution within the target volume. Dosimetric uncertainty associated with conventional in vivo irradiation procedures prohibits their ability to accurately determine tumor response to non-uniform radiation fields and stresses the need for image guided small animal radiation research platforms.

Entities:  

Keywords:  Bystander; bioluminescent imaging; in vivo; non-uniform; tumor burden

Mesh:

Substances:

Year:  2014        PMID: 25347147     DOI: 10.3109/09553002.2014.980468

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  4 in total

1.  Modelling responses to spatially fractionated radiation fields using preclinical image-guided radiotherapy.

Authors:  Karl Terence Butterworth; Mihaela Ghita; Stephen J McMahon; Conor K Mcgarry; Robert J Griffin; Alan R Hounsell; Kevin M Prise
Journal:  Br J Radiol       Date:  2016-09-15       Impact factor: 3.039

2.  Bioluminescence Tomography-Guided Radiation Therapy for Preclinical Research.

Authors:  Bin Zhang; Ken Kang-Hsin Wang; Jingjing Yu; Sohrab Eslami; Iulian Iordachita; Juvenal Reyes; Reem Malek; Phuoc T Tran; Michael S Patterson; John W Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-14       Impact factor: 7.038

3.  Evaluation of On- and Off-Line Bioluminescence Tomography System for Focal Irradiation Guidance.

Authors:  Bin Zhang; John W Wong; Iulian I Iordachita; Juvenal Reyes; Katriana Nugent; Phuoc T Tran; Stephen W Tuttle; Constantinos Koumenis; Ken Kang-Hsin Wang
Journal:  Radiat Res       Date:  2016-11-21       Impact factor: 2.841

4.  Bone marrow mesenchymal stem cells promote prostate cancer cell stemness via cell-cell contact to activate the Jagged1/Notch1 pathway.

Authors:  Ji-Wen Cheng; Li-Xia Duan; Yang Yu; Pu Wang; Jia-le Feng; Guan-Zheng Feng; Yan Liu
Journal:  Cell Biosci       Date:  2021-05-17       Impact factor: 7.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.